Skip to main content
Premium Trial:

Request an Annual Quote

Pairings: Sep 9, 2009


DxS announced this week the appointment of Patrik Dahlen as its non-executive director. Dahlen, former CEO of the diagnostics firm Dako, brings to DxS 15 years of experience in the industry. He was previously the CEO of the Danish biotech BioImage, and president of life sciences and vice president at PerkinElmer. Dahlen is on the boards of Proxeon, Olink, DakoCytomation, and Cantion.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.